MedPath

Survey of the seroprevalence and infection status of SARS-CoV-2 among employees of the University Hospital Jena (COVID-19)

Conditions
07.1 COVID-19
Registration Number
DRKS00022432
Lead Sponsor
niversitätsklinikum Jena
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
725
Inclusion Criteria

Employee at the UKJ. Presence of informed consent to participate in the study.

Exclusion Criteria

none

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Co-HCW study is intended to investigate the Covid-19 seroprevalence of employees of the University Hospital Jena longitudinally (3 measurement points at intervals of 4-6 months each).
Secondary Outcome Measures
NameTimeMethod
Clinical areas with CoVID-19 patients will be compared with areas without patient contact. The risk of nosocomial infection and of infection outside the UKJ will be assessed by means of a questionnaire.
© Copyright 2025. All Rights Reserved by MedPath